Navigation Links
Arpida Interim Results for six Months to 30 June 2007
Date:8/28/2007

SSI.

With a view to a potential launch of intravenous iclaprim in 2008, we are significantly expanding our medical and scientific communications. A total of 24 abstracts on iclaprim have been accepted at the upcoming ICAAC and IDSA conferences in the USA. We are eager to share our preclinical and clinical data with the medical and scientific community.

Dr Islam added: Progress was not limited to our most advanced programme, but was seen across the board. It included the authorisation from the US FDA to initiate Phase II trials with intravenous iclaprim in hospital-acquired pneumonia, as well as steady progress in other programmes such as oral iclaprim, AR-709 and AR-2474. Looking at the disturbing increase and the broadening of bacterial resistance against many of the current drugs, I feel these antibiotic programmes are aimed at significant existing or emerging medical needs.

Very recently, we succeeded in broadening our clinical pipeline further by acquiring the late-stage anti-fungal TLT therapy. TLT is about to enter Phase III clinical trials in Europe targeting onychomycosis an important indication, affecting dozens of millions of people worldwide.

Dr Islam concluded: Overall I can say that Arpida remains on a steady, successful course, strengthening the foundations for a profitable future.

Financial review for six months to 30 June 2007

Key financial indicators

(CHF million) 2007 H1 2006 H2 2006 H1

Research and development expenses (27.7) (40.8) (23.9)

Management and general expenses (6.0) (4.6) (4.6)

Total operating expenses (33.7) (45.4) (28.5)

Net result (33.8) (44.6) (27.9)

Cash and financial investments end of 94.7 72.8 98.6

period

Equity end of period 87.7 65.5 104.9

Res
'/>"/>

SOURCE Arpida
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Effects of Thermal Cycler Well-To-Well Temperature Uniformity on PCR Results
2. HotMasterAn innovative Hot Start/Cold Stop technology for better PCR* results
3. Achieving Reliable Protein Quantitation Results Using ICAT Reagents, MALDITOF Mass Spectrometry, and Advanced Data Interpretation Tool
4. How Best Buy said bye to burnout, hello to results
5. Economic survey reveals better 2006 results
6. Third Wave Reports Third-Quarter Financial Results
7. Tech Digest: Merge eMed product updates; Renaissance Learning 3rd qtr results
8. Midwest small-cap life sciences turn in mixed third-quarter results
9. To boost advertising results, consider improving your web site
10. RedPrairie Reports Strong Results
11. 2003 Biotech Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... SAN DIEGO and BETHESDA, Md. ... they are joining together with two institutes from the ... more reliable tools for bringing safer, more effective treatments ... with the National Center for Advancing Translational Sciences (NCATS) ...
(Date:1/14/2014)... WESTBOROUGH, Mass. , Jan. 14, 2014  RXi ... on discovering, developing and commercializing innovative therapies addressing ... announced that it received the Notice of Allowance ... on its unique self-delivering RNAi compounds (sd-rxRNA®), for ...
(Date:1/14/2014)... Cardiff, UK (PRWEB) January 13, 2014 ... leader with more than 20 years in the industry, ... and photonics . Hainsey will serve as the society’s ... have Dr. Hainsey join SPIE as our Technology Strategist, ...
(Date:1/14/2014)... 2014 Independent publisher Bitingduck Press, with ... Canada, has big ideas for 2014 in production and ... are to produce high-quality, low-cost, DRM-free ebooks and to ... , The first major development will be bookstore ...
Breaking Biology Technology:Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... KONG, Feb. 18 /PRNewswire-Asia/ -- Obio Pharmaceutical ... growth ticket to the,international pharmaceutical arena. With ... up by strong international investors including Yangtze,Ventures ... Tai Sang Land Properties,Limited, Yu Hwa Chinese ...
... 18 PharmaNet Development Group, Inc. (the "Company") (Nasdaq: ... development services to innovative pharmaceutical, biotechnology, generic drug and ... new office in Sao Paulo, Brazil to further enhance ... support in Latin America since 2002 with a network ...
... Feb. 18 Senesco Technologies, Inc. ("Senesco" or ... for the three months ended December 31, 2008. Net loss ... $1,624,341, or $0.09 per share, compared with a net loss ... period ended December 31, 2007. This increase in net ...
Cached Biology Technology:Obio Pharmaceutical Announces Product Growth Strategy 2Obio Pharmaceutical Announces Product Growth Strategy 3PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 2PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 3PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 4PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 5Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 2Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 3Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 4Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 5Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 6Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 7
(Date:4/17/2014)... Press journal Current Biology on April 17 ... lives. The Brazilian insects, which represent four distinct but ... the first example of an animal with sex-reversed genitalia. ... several different animals, Neotrogla is the only ... says Kazunori Yoshizawa from Hokkaido University in Japan. , ...
(Date:4/17/2014)... Pine forests are chock full of wild animals and ... populations of fungi are churning away in the soil, ... , Despite the vital role these fungi play in ... A Stanford-led team of scientists has generated a genetic ... North America. The work was published this week in ...
(Date:4/17/2014)... domestication derive from Charles Darwin, whose ideas in ... during the 19th century, a period when landowners ... is from Darwin that we inherit the ideas ... wild species and total human control over breeding ... this industrial setting has been applied too broadly ...
Breaking Biology News(10 mins):In sex-reversed cave insects, females have the penises 2Stanford biologists help solve fungal mysteries 2Stanford biologists help solve fungal mysteries 3The story of animal domestication retold 2The story of animal domestication retold 3The story of animal domestication retold 4
... L. Weber argues that China,s new title as the ... due to consumption of Chinese goods in the West. ... in the 2008 Olympic Games in Beijing, there is ... caused by smoke and smog from coal-fired plants that ...
... scientists will receive EMBO Installation Grants, assisting them to ... two scientists will receive funding in 2008 similar to ... European Molecular Biology Organization (EMBO) introduced the scheme in ... aim to strengthen science in selected member states of ...
... 2008) -- In a first, scientists from Weill Cornell ... the specifics of how brain cells process antidepressant drugs, ... in the development of more targeted medication therapies for ... area of addiction. Their breakthrough research, featured as ...
Cached Biology News:Carnegie Mellon Researcher says China's export trade impacts climate 2Scientists in Hungary and Portugal get research boost 2N.Y. research team discovers how antidepressants and cocaine interact with brain cell targets 2N.Y. research team discovers how antidepressants and cocaine interact with brain cell targets 3
... Direct In Situ Apoptosis Detection ... situ by the direct TUNEL ... tagged with a directly labeled ... fluorescence staining for 40 samples ...
... Kit is a two color staining ... cellular DNA to detect apoptotic cells by ... instructions and reagents required for measuring apoptosis ... cells for assessing reagent performance; washing, reaction, ...
The stirbar is used in the buffer tank of the Trans-Blot Plus cell to maintain uniform conductivity and temperature during electrophoretic transfer. Dimensions are 3.5 x 0.5 in....
... is the latest entry in the Biomek line. ... and increased robustness, it can meet the needs ... configured with either one or two pipetting pods. ... sets the standard for flexible laboratory solutions to ...
Biology Products: